178 related articles for article (PubMed ID: 23688317)
1. Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements.
Tran AT; Straand J; Dalen I; Birkeland KI; Claudi T; Cooper JG; Meyer HE; Jenum AK
BMC Health Serv Res; 2013 May; 13():182. PubMed ID: 23688317
[TBL] [Abstract][Full Text] [Related]
2. Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway.
Tran AT; Diep LM; Cooper JG; Claudi T; Straand J; Birkeland K; Ingskog W; Jenum AK
BMC Health Serv Res; 2010 May; 10():145. PubMed ID: 20507647
[TBL] [Abstract][Full Text] [Related]
3. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
[TBL] [Abstract][Full Text] [Related]
4. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
[TBL] [Abstract][Full Text] [Related]
5. Joint and distinct risk factors associated with micro- and macrovascular complications in a cohort of type 2 diabetic patients cared through disease management.
Ciardullo AV; Daghio MM; Bevini M; Feltri G; Novi D; Fattori G; Borsari S; Donato CD
Acta Diabetol; 2010 Dec; 47(4):301-8. PubMed ID: 20383650
[TBL] [Abstract][Full Text] [Related]
6. Ethnic and gender differences in the management of type 2 diabetes: a cross-sectional study from Norwegian general practice.
Tran AT; Berg TJ; Gjelsvik B; Mdala I; Thue G; Cooper JG; Nøkleby K; Claudi T; Bakke Å; Sandberg S; Jenum AK
BMC Health Serv Res; 2019 Nov; 19(1):904. PubMed ID: 31779621
[TBL] [Abstract][Full Text] [Related]
7. Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014.
Tran AT; Bakke Å; Berg TJ; Gjelsvik B; Mdala I; Nøkleby K; Shakil Rai A; Cooper JG; Claudi T; Løvaas K; Thue G; Sandberg S; Jenum AK
Scand J Prim Health Care; 2018 Jun; 36(2):170-179. PubMed ID: 29717939
[TBL] [Abstract][Full Text] [Related]
8. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
Boytsov S; Logunova N; Khomitskaya Y;
Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians.
Tran AT; Straand J; Diep LM; Meyer HE; Birkeland KI; Jenum AK
BMC Public Health; 2011 Jul; 11():554. PubMed ID: 21752237
[TBL] [Abstract][Full Text] [Related]
10. Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.
Camara S; Bouenizabila E; Hermans MP; Ahn SA; Rousseau MF
Diabetes Metab Syndr; 2014; 8(3):145-51. PubMed ID: 25220917
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
[TBL] [Abstract][Full Text] [Related]
12. Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks.
Bergenstal RM; Li Y; Porter TK; Weaver C; Han J
Diabetes Obes Metab; 2013 Mar; 15(3):264-71. PubMed ID: 23078638
[TBL] [Abstract][Full Text] [Related]
13. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes.
Gouni-Berthold I; Berthold HK; Mantzoros CS; Böhm M; Krone W
Diabetes Care; 2008 Jul; 31(7):1389-91. PubMed ID: 18375411
[TBL] [Abstract][Full Text] [Related]
14. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.
Banegas JR; López-García E; Dallongeville J; Guallar E; Halcox JP; Borghi C; Massó-González EL; Jiménez FJ; Perk J; Steg PG; De Backer G; Rodríguez-Artalejo F
Eur Heart J; 2011 Sep; 32(17):2143-52. PubMed ID: 21471134
[TBL] [Abstract][Full Text] [Related]
15. Variation in the achievement of HbA
Bakke Å; Dalen I; Thue G; Cooper J; Skeie S; Berg TJ; Jenum AK; Claudi T; Fjeld Løvaas K; Sandberg S
Diabet Med; 2020 Sep; 37(9):1471-1481. PubMed ID: 31651045
[TBL] [Abstract][Full Text] [Related]
16. Can traditional risk factors explain the higher risk of cardiovascular disease in South Asians compared to Europeans in Norway and New Zealand? Two cohort studies.
Rabanal KS; Meyer HE; Tell GS; Igland J; Pylypchuk R; Mehta S; Kumar B; Jenum AK; Selmer RM; Jackson R
BMJ Open; 2017 Dec; 7(12):e016819. PubMed ID: 29217719
[TBL] [Abstract][Full Text] [Related]
17. Personalised treatment targets in type 2 diabetes patients: The Dutch approach.
Boels AM; Hart HE; Rutten GE; Vos RC
Prim Care Diabetes; 2017 Feb; 11(1):71-77. PubMed ID: 27633894
[TBL] [Abstract][Full Text] [Related]
18. Seasonal Variations in the Achievement of Guideline Targets for HbA
Sakamoto M; Matsutani D; Minato S; Tsujimoto Y; Kayama Y; Takeda N; Ichikawa S; Horiuchi R; Utsunomiya K; Nishikawa M
Diabetes Care; 2019 May; 42(5):816-823. PubMed ID: 30739885
[TBL] [Abstract][Full Text] [Related]
19. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
Wens J; Gerard R; Vandenberghe H
Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
[TBL] [Abstract][Full Text] [Related]
20. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.
Charpentier G; Genès N; Vaur L; Amar J; Clerson P; Cambou JP; Guéret P;
Diabetes Metab; 2003 Apr; 29(2 Pt 1):152-8. PubMed ID: 12746636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
